MIP is a holistic behavioral intervention for reducing high-risk behaviors for infection and transmission of HIV among intravenous drug users (IDUs). The intervention is theory-driven and intensive, combining individualized counseling and comprehensive case management over a 3-6-month period. The strategies of motivational counseling, self efficacy, and role induction are used.
Important CDC Update:
The CDC’s strategy for High Impact HIV Prevention involves prioritizing and implementing an optimal combination of cost-effective, scalable interventions based on the current state of the science. This shift should help improve the effectiveness of HIV prevention efforts, reduce HIV incidence, and ultimately increase the possibility of achieving an AIDS-free America. In its ongoing effort to align HIV prevention resources with current surveillance data and this strategy, the Division of HIV/AIDS Prevention (DHAP) at CDC will not offer trainings or capacity building assistance on the following evidence-based interventions (EBIs): AIM, ¡Cuídate!, Focus on Youth, MIP, Nia, RAPP, Safety Counts, SHIELD, SIHLE, SISTA, Street Smart, RESPECT and VOICES/VOCES (except when used with MSM). The Division also will not offer trainings or capacity building assistance on some new EBIs, such as Healthy Love. Health departments or other funders may continue to support implementation of these EBIs, and the implementation materials for all these interventions will remain on this site and be available for download. If you have additional questions about this issue, please contact firstname.lastname@example.org.
CDC’s Division of Reproductive Health (DRH) will provide support to their grantees on AIM, ¡Cuídate!, and SIHLE. For further information on DRH’s efforts, please contact Trisha Mueller at email@example.com.
How to request MIP training and technical assistance
As listed above, CDC no longer offers training or capacity building for MIP. If MIP training is desired, contact any of the MIP trainers within the following organizations listed below to make individual arrangements to obtain training. You are welcome also to contact the original researchers. All costs associated with receiving MIP training will be paid by the requesting agency or individual. Here's a printer friendly version of the MIP Master Trainer List.
Sarahjane Rath, MPH, CHES
Capacity Building Coordinator
Gisele Pemberton, DrPH, MPH, CHES
Director, National Center for Training, Support and Technical Assistance
1126 Dickinson Street
Elizabeth, NJ 07201
Direct: (908) 351-7727
Main: (908) 351-7727
Harm Reduction Coalition (HRC)
Narelle Ellendon, RN Director of Capacity Building Services 22 West 27th Street,
5th Floor New York, NY 10001
Direct: (212) 213-6376, ext. 16
Research and Development
Robles R, Reyes J, Colon H, Sahai H, Marrero A, Matos T, Calderon J, Shepard E. Effects of combined counseling and case management to reduce HIV risk behaviors among Hispanic drug injectors in Puerto Rico: A randomized controlled study. Journal of Substance Abuse Treatment. 2004;27:145-152.
Marrero, CA, Robles RR, Colon HM, Reyes JC, Matos TM, Sahai H., et al. Factors associated with drug treatment dropout among injection drug users in Puerto Rico. Addictive Behaviors. 2005; 30:397-402.
Program Review Panel Information
The CDC requires all CDC-funded agencies using the Modelo de Intervención Psicomédica (MIP) intervention to identify, or establish, and utilize a Program Review Panel and complete Form 0.1113 to document this activity. The intervention researchers and developers are not involved in this activity. This is a CDC requirement for their grantees, and all questions in this regard should be directed to your agency's CDC Project Officer or to the health department funding your agency's implementation of the intervention.
The Program Review Panel guidelines, instructions for completion of Form 0.113, and the form itself are available under the Related Links section of this website.